BlackRock Institutional Trust Company, N.A. - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$60,486,000
-7.1%
4,862,195
+2.2%
0.01%
-10.0%
Q3 2016$65,107,000
+93.8%
4,755,820
+4.6%
0.01%
+100.0%
Q2 2016$33,599,000
+16.7%
4,546,501
+0.9%
0.01%0.0%
Q1 2016$28,784,000
+1.9%
4,504,518
-0.4%
0.01%0.0%
Q4 2015$28,259,000
+11.9%
4,521,436
+4.6%
0.01%
+25.0%
Q3 2015$25,250,000
-34.5%
4,323,671
-7.3%
0.00%
-33.3%
Q2 2015$38,576,000
-4.4%
4,664,568
-4.8%
0.01%0.0%
Q1 2015$40,372,000
+19.8%
4,899,564
-0.1%
0.01%
+20.0%
Q4 2014$33,686,000
+29.6%
4,903,278
+1.8%
0.01%
+25.0%
Q3 2014$25,999,000
-15.5%
4,814,669
-0.3%
0.00%
-20.0%
Q2 2014$30,757,000
-16.7%
4,828,394
+5.4%
0.01%
-16.7%
Q1 2014$36,913,000
+12.5%
4,579,777
-4.8%
0.01%0.0%
Q4 2013$32,816,000
-60.0%
4,811,658
+8.0%
0.01%
-62.5%
Q3 2013$81,971,000
+3.9%
4,454,971
-1.2%
0.02%0.0%
Q2 2013$78,897,0004,510,9550.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,331,100$23,281,0008.28%
DAFNA Capital Management LLC 191,215$3,344,0004.89%
Redmile Group, LLC 1,277,109$22,337,0003.94%
BB BIOTECH AG 3,115,371$54,488,0003.92%
SECTORAL ASSET MANAGEMENT INC 5,292,682$92,569,0002.74%
IRONWOOD INVESTMENT MANAGEMENT LLC 565,956$9,899,0001.76%
OAK RIDGE INVESTMENTS LLC 2,645,781$46,275,0001.45%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,104$22,127,0001.04%
Tekla Capital Management LLC 412,965$7,223,0000.98%
Private Capital Advisors, Inc. 127,600$2,232,0000.83%
View complete list of ARIAD PHARMACEUTICALS INC shareholders